Kung Sung-Pao, Lui Wing-Yiu
Department of Surgery, Taipei Veterans General Hospital, and National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.
Zhonghua Yi Xue Za Zhi (Taipei). 2002 Aug;65(8):392-7.
Transferrin is a useful index of visceral protein, but it is unknown whether changes in the level of transferrin can be used as a prognostic marker for patients receiving nutrition support.
Consecutive in one-year period, we recorded the data of 325 patients who with unusable gastrointestinal tract received total parenteral nutrition (TPN) for more than 2 weeks. The data included the levels of serum transferrin, albumin, total bilirubin, hemoglobin and white blood cell before and after 2-week nutrition support. Age, sex, body weight, diagnosis, and hospital outcome were also recorded. A total of 305 patients with complete initial data and 221 patients with data on TPN-induced level change were enrolled and evaluated statistically.
The mortality rate was 47.6% in the group of patients who showed no increase of serum transferrin after 2 weeks of TPN. Univariate analysis revealed that the initial level and TPN-induced changes of serum transferrin, albumin and total bilirubin were significantly correlated with patient survival. However, multivariate analysis showed that the initial level of transferrin, albumin, total bilirubin and the TPN-induced level changes in transferrin were independent factors significantly correlated with patient survival. Two of the most the significant factors among them were initial level of transferrin (p < 0.0001, odds ratio = 2.4838) and change in serum transferrin level after 2 weeks of TPN (p < 0.0001, odds ratio = 2.664).
Changes in serum transferrin level in patients with intestinal failure who received TPN for 2 weeks appear to be a good indicator of patient outcome.
转铁蛋白是一种有用的内脏蛋白指标,但转铁蛋白水平的变化是否可作为接受营养支持患者的预后标志物尚不清楚。
连续一年,我们记录了325例胃肠道功能不可用且接受全胃肠外营养(TPN)超过2周患者的数据。数据包括2周营养支持前后的血清转铁蛋白、白蛋白、总胆红素、血红蛋白和白细胞水平。还记录了年龄、性别、体重、诊断和住院结局。共纳入305例初始数据完整的患者和221例有TPN诱导水平变化数据的患者,并进行统计学评估。
TPN治疗2周后血清转铁蛋白未升高的患者组死亡率为47.6%。单因素分析显示,血清转铁蛋白、白蛋白和总胆红素的初始水平及TPN诱导的变化与患者生存显著相关。然而,多因素分析表明,转铁蛋白、白蛋白、总胆红素的初始水平以及转铁蛋白的TPN诱导水平变化是与患者生存显著相关的独立因素。其中两个最显著的因素是转铁蛋白的初始水平(p < 0.0001,比值比 = 2.4838)和TPN治疗2周后血清转铁蛋白水平的变化(p < 0.0001,比值比 = 2.664)。
接受TPN治疗2周的肠衰竭患者血清转铁蛋白水平的变化似乎是患者预后的良好指标。